EP1303541B1 — Compositions containing metronidazole
Assigned to Dow Pharmaceutical Sciences Inc · Expires 2011-04-27 · 15y expired
What this patent protects
An aqueous solution of metronidazole in which the concentration of metronidazole is higher than 0.75 %. The solution contains the solubility enhancer hydroxypropyl-betacyclodextrin and may additionally contain niacinamide. Methods of manufacture and therapeutic use of the solutio…
USPTO Abstract
An aqueous solution of metronidazole in which the concentration of metronidazole is higher than 0.75 %. The solution contains the solubility enhancer hydroxypropyl-betacyclodextrin and may additionally contain niacinamide. Methods of manufacture and therapeutic use of the solution are disclosed.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.